1. Home
  2. ALLT vs HUMA Comparison

ALLT vs HUMA Comparison

Compare ALLT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$7.06

Market Cap

364.0M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.36

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
HUMA
Founded
1996
2004
Country
Israel
United States
Employees
N/A
184
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.0M
308.6M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ALLT
HUMA
Price
$7.06
$1.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$12.40
$6.19
AVG Volume (30 Days)
505.0K
7.5M
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.84
$444.16
Revenue Next Year
$12.09
$248.39
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.12
$0.55
52 Week High
$11.92
$2.84

Technical Indicators

Market Signals
Indicator
ALLT
HUMA
Relative Strength Index (RSI) 42.63 58.66
Support Level $6.98 $0.89
Resistance Level $7.32 $1.87
Average True Range (ATR) 0.34 0.13
MACD -0.10 0.01
Stochastic Oscillator 0.60 66.93

Price Performance

Historical Comparison
ALLT
HUMA

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: